Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013. (Q37577159)
Jump to navigation
Jump to search
scientific article published on August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013. |
scientific article published on August 2013 |
Statements
1 reference
Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013. (English)
1 reference
Guntram Schernthaner
1 reference
Craig J Currie
1 reference
Gerit-Holger Schernthaner
1 reference
1 August 2013
1 reference
1 reference
36 Suppl 2
1 reference
S155-61
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference